trial

Ziprasidone for Clozapine- or Olanzapine-Associated Diabetes Mellitus

NCTId NCT00351000
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 24 (actual)
Sponsored by North Suffolk Mental Health Association
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
24 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2005-01
Primary completion
—
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Ziprasidone

Sponsors

North Suffolk Mental Health AssociationLead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Collaborator

Investigators

1
David C. Henderson, MDPrincipal Investigator

Sites

1 total
Boston, United States

Facts & assertions

3 sourced
Enrollment
24
Phase
PHASE4
Status
COMPLETED
relationships
The graph out of here
drug
Ziprasidone
drug
lead_sponsor
North Suffolk Mental Health Association
company
collaborator
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
company
indication
Schizophrenia
indication
Schizophrenia
indication
Insulin Resistance
indication
investigator
David C. Henderson, MD
person